Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members

Author:

Gonzalo-Gil Elena1ORCID,Rapuano Patrick B1,Ikediobi Uchenna1,Leibowitz Rebecca1,Mehta Sameet2,Coskun Ayse K1,Porterfield J Zachary1,Lampkin Teagan D3,Marconi Vincent C4,Rimland David4,Walker Bruce D5,Deeks Steven67ORCID,Sutton Richard E1ORCID

Affiliation:

1. Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States

2. Yale Center for Genome Analysis Bioinformatics group, Yale University School of Medicine, New Haven, United States

3. Infectious Diseases Section, Dallas VA Medical Center, Dallas, United States

4. Atlanta VA Medical Center, Emory University School of Medicine, Atlanta, United States

5. Ragon Institute of MGH, MIT and Harvard University, Cambridge, United States

6. Department of Medicine, University of California San Francisco, San Francisco, United States

7. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States

Abstract

HIV +Elite and Viremic controllers (EC/VCs) are able to control virus infection, perhaps because of host genetic determinants. We identified 16% (21 of 131) EC/VCs with CD4 +T cells with resistance specific to R5-tropic HIV, reversed after introduction of ccr5. R5 resistance was not observed in macrophages and depended upon the method of T cell activation. CD4 +T cells of these EC/VCs had lower ccr2 and ccr5 RNA levels, reduced CCR2 and CCR5 cell-surface expression, and decreased levels of secreted chemokines. T cells had no changes in chemokine receptor mRNA half-life but instead had lower levels of active transcription of ccr2 and ccr5, despite having more accessible chromatin by ATAC-seq. Other nearby genes were also down-regulated, over a region of ~500 kb on chromosome 3p21. This same R5 resistance phenotype was observed in family members of an index VC, also associated with ccr2/ccr5 down-regulation, suggesting that the phenotype is heritable.

Funder

National Institutes of Health

Bill and Melinda Gates Foundation

Harvard University Center for AIDS Research

The Collaboration for AIDS Vaccine Discovery

UCSF/Gladstone Institute of Virology and Immunology

CFAR Network of Integrated Systems

Delaney AIDS Research Enterprise

The amfAR Institute for HIV cure research

National Institute on Drug Abuse

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3